首页> 外文期刊>Indian journal of dermatology, venereology and leprology >In vitro susceptibility of dermatophytes to oral antifungal drugs and amphotericin B in Uttar Pradesh, India
【24h】

In vitro susceptibility of dermatophytes to oral antifungal drugs and amphotericin B in Uttar Pradesh, India

机译:印度北方邦的皮肤真菌对口服抗真菌药和两性霉素B的体外敏感性

获取原文
           

摘要

Background: Dermatophytosis is a major public health problem in our country. Although resistance to conventional oral and topical antifungal agents is being increasingly encountered, the sensitivity pattern of dermatophytes has not been systematically analysed. Aims: We aimed to determine the sensitivity pattern of dermatophyte isolates to amphotericin B and six oral antifungal drugs. Materials and Methods: Patients with dermatophytosis attending the outpatient department of dermatology were enrolled in the study. Samples were collected for mycological examination and in vitro antifungal sensitivity testing was done by broth microdilution as per the Clinical and Laboratory Standard Institute M38-A standards. Results: A total of 804 patients were enrolled. Specimens from 185 patients (23%) were both KOH and culture positive, and 44 of these isolates (41 Trichophyton mentagrophytes and 3 Trichophyton rubrum) were subjected to sensitivity testing. Minimum inhibitory concentrations (MIC) of itraconazole, ketoconazole, voriconazole and amphotericin B were comparable. The median MIC to fluconazole was higher than the other tested drugs. Dermatophytes were most susceptible to ketoconazole and voriconazole, followed by itraconazole, amphotericin B, fluconazole and griseofulvin. A high incidence of resistance was found to terbinafine and the difference was statistically significant in comparison to fluconazole, itraconazole, voriconazole, ketoconazole (P = 0.001) and griseofulvin (P = 0.003). The strains were more sensitive to amphotericin B as compared to griseofulvin (P = 0.02) and terbinafine (P Limitations: This was a hospital-based study and may not reflect the true pattern in the community. Only a few of the isolates were selected for study. The clinical response of patients, whose isolates were studied for in vitro sensitivity of the antifungals, was not studied. Conclusions: The sensitivity pattern of dermatophytes to various antifungals including amphotericin B, ketoconazole, voriconazole and itraconazole were determined. The studied isolates were least susceptible to terbinafine.
机译:背景:皮肤癣菌病是我国的主要公共卫生问题。尽管对常规口服和局部抗真菌剂的耐药性越来越高,但是尚未对皮肤真菌的敏感性模式进行系统分析。目的:我们旨在确定皮肤真菌分离物对两性霉素B和六种口服抗真菌药的敏感性模式。材料与方法:参加皮肤科门诊就诊的皮肤癣菌病患者。收集样品用于真菌学检查,并按照临床和实验室标准协会M38-A标准,通过肉汤微量稀释进行体外抗真菌敏感性测试。结果:共纳入804例患者。来自185例患者(23%)的标本均为KOH且培养呈阳性,并对其中的44株分离物(41种毛癣菌和3种毛癣菌)进行了敏感性测试。伊曲康唑,酮康唑,伏立康唑和两性霉素B的最低抑菌浓度(MIC)相当。氟康唑的中位MIC高于其他测试药物。皮肤癣菌对酮康唑和伏立康唑最敏感,其次是伊曲康唑,两性霉素B,氟康唑和灰黄霉素。发现特比萘芬耐药的发生率很高,与氟康唑,伊曲康唑,伏立康唑,酮康唑(P = 0.001)和灰黄霉素(P = 0.003)相比,差异具有统计学意义。与灰黄霉素(P = 0.02)和特比萘芬(P限制)相比,该菌株对两性霉素B更为敏感:这是一项基于医院的研究,可能无法反映社区的真实模式,仅从其中分离出了几株结论:确定了皮肤真菌对两性霉素B,酮康唑,伏立康唑和伊曲康唑等多种抗真菌药的敏感性模式,并确定了其分离株对抗真菌药的体外敏感性的临床反应。对特比萘芬最不敏感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号